Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs. Aflibercept in Patients With Diabetic Macular Edema
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 26 Oct 2017 Status changed from recruiting to completed.
- 17 Oct 2016 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
- 17 Oct 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.